Publications by authors named "Norbert Vella"

Claim this Profile
P
Paroxysmal dysarthria-ataxia syndrome.
Marija Cauchi, Janice Abela, Nicola Dingli, Norbert Vella

Pract Neurol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine-learning-based prediction of disability progression in multiple sclerosis: An observational, international, multi-center study.
Edward De Brouwer, Thijs Becker, Lorin Werthen-Brabants, Pieter Dewulf, Dimitrios Iliadis, Norbert Vella

PLOS Digit Health· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel phenotype of AChR-deficiency syndrome with predominant facial and distal weakness resulting from the inclusion of an evolutionary alternatively-spliced exon in CHRNA1.
Pedro M Rodríguez Cruz, Gianina Ravenscroft, Daniel Natera, Aisling Carr, Adnan Manzur, Norbert R Vella

Neuromuscul Disord· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Missense mutations in small muscle protein X-linked (SMPX) cause distal myopathy with protein inclusions.
Mridul Johari, Jaakko Sarparanta, Anna Vihola, Per Harald Jonson, Marco Savarese, Norbert Vella

Acta Neuropathol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cocaine-induced toxic leucoencephalopathy with complete clinical recovery.
Ylenia Abdilla, Marija Cauchi, Norbert Vella

BMJ Case Rep· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-HMGCR antibody-associated necrotising myopathy and its association with statin use.
Ylenia Abdilla, Charmaine Chircop, Norbert Vella

BMJ Case Rep· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple sclerosis in Latin America: A different disease course severity? A collaborative study from the MSBase Registry.
Juan Ignacio Rojas, Liliana Patrucco, Maria Trojano, Alessandra Lugaresi, Guillermo Izquierdo, Norbert Vella

Mult Scler J Exp Transl Clin· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of disability worsening in clinically isolated syndrome.
Vilija G Jokubaitis, Tim Spelman, Tomas Kalincik, Guillermo Izquierdo, François Grand'Maison, Norbert Vella

Ann Clin Transl Neurol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seasonal variation of relapse rate in multiple sclerosis is latitude dependent.
Tim Spelman, Orla Gray, Maria Trojano, Thor Petersen, Guillermo Izquierdo, Norbert Vella

Ann Neurol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of relapse phenotype recurrence in multiple sclerosis.
Tomas Kalincik, Katherine Buzzard, Vilija Jokubaitis, Maria Trojano, Pierre Duquette, Norbert Vella

Mult Scler· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors and dynamics of postpartum relapses in women with multiple sclerosis.
Stella E Hughes, Tim Spelman, Orla M Gray, Cavit Boz, Maria Trojano, Norbert Vella

Mult Scler· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis.
Tomas Kalincik, Vino Vivek, Vilija Jokubaitis, Jeannette Lechner-Scott, Maria Trojano, Norbert Vella

Brain· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How does fingolimod (gilenya(®)) fit in the treatment algorithm for highly active relapsing-remitting multiple sclerosis?
Franz Fazekas, Ovidiu Bajenaru, Thomas Berger, Tanja Hojs Fabjan, Alenka Horvat Ledinek, Norbert Vella

Front Neurol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Country, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndrome.
Claire Meyniel, Timothy Spelman, Vilija G Jokubaitis, Maria Trojano, Guillermo Izquierdo, Norbert Vella

PLoS One· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fingolimod in the treatment algorithm of relapsing remitting multiple sclerosis: a statement of the Central and East European (CEE) MS Expert Group.
Franz Fazekas, Thomas Berger, Tanja Hojs Fabjan, Alenka Horvat Ledinek, Gábor Jakab, Norbert Vella

Wien Med Wochenschr· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demyelination during anti-TNFα therapy for ankylosing spondylitis.
Cecilia Mercieca, Norbert Vella, Andrew A Borg

Mod Rheumatol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry.
Stella Hughes, Timothy Spelman, Maria Trojano, Alessandra Lugaresi, Guillermo Izquierdo, Norbert Vella

J Neurol Neurosurg Psychiatry· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paraneoplastic cerebellar ataxia due to burnt-out testicular germ cell tumour?
Bart P C van de Warrenburg, Manuel Rodriguez-Justo, Norbert R Vella, Alex Freeman, Kailash P Bhatia

Eur Neurol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis